<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641886</url>
  </required_header>
  <id_info>
    <org_study_id>20140700108a</org_study_id>
    <nct_id>NCT02641886</nct_id>
  </id_info>
  <brief_title>The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction</brief_title>
  <official_title>A Study to Evaluate the Safety and Efficacy of Jian Pi Yi Shen Hua Tan Granules in Patients With Cognitive Impairment After Acute Cerebral Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Changchun University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangmen Wuyi Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shunyi Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the chinese medicine Jian Pi Yi Shen Hua
      Tan granules is effective in the treatment of cognitive impairment after acute cerebral
      infarction .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study is designed to observe the symptoms,syndrome characteristics and
      neuropsychological changes of patients with cognitive dysfunction after Acute Cerebral
      Infarction, as well as study the patterns of syndrome evolution and neuropsychological
      characteristics, in order to provide evidences for the early-stage identification, diagnosis,
      intervention and treatment based on syndrome differentiation.

      To assess the effectiveness of applying early-stage prevention on patients with cognitive
      impairment after Acute Cerebral Infarction through the use of traditional Chinese
      medicine--Jian Pi Yi Shen Hua Tan granules, explore the pathogenesis and therapeutic efficacy
      mechanism, evaluate the effectiveness of early-stage prevention and provide alternative
      solutions for preventing or delaying dementia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mini-mental state examination</measure>
    <time_frame>90 days</time_frame>
    <description>Using mini-mental state examination to examine the patients' cognitive function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment scale</measure>
    <time_frame>90 days</time_frame>
    <description>Using Montreal Cognitive Assessment scale to examine the patients' cognitive function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroop test</measure>
    <time_frame>90 days</time_frame>
    <description>Using Stroop test to examine executive function and attention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical sequence test（DS-S)</measure>
    <time_frame>90 days</time_frame>
    <description>Using Numerical sequence test（DS-S) to examine memeory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Digital color connection test (CCT)</measure>
    <time_frame>90 days</time_frame>
    <description>Using Numerical sequence test（DS-S) to examine executive function and attention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Verbal memory test(HVLT)</measure>
    <time_frame>90 days</time_frame>
    <description>Using Verbal memory test(HVLT) to examine verbal memory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>national institute of health stroke scale</measure>
    <time_frame>90 days</time_frame>
    <description>Using national institute of health stroke scale to examine the neurologic function impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin scale</measure>
    <time_frame>90 days</time_frame>
    <description>Using modified Rankin scale to examine the recovery of neurologic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity of Daily Living Scale</measure>
    <time_frame>90 days</time_frame>
    <description>Using Activity of Daily Living Scale to examine daily living ability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>scores of Chinese medicine symptoms</measure>
    <time_frame>90 days</time_frame>
    <description>Using the scores of Chinese medicine symptoms to examine the Chinese medicine syndrom</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Jian Pi Yi Shen Hua Tan Granules group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treat with the prescription of Jianpi Yishen Huatan Granules and conventional treatment of ischemic stroke.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treat with the placebo which contain 5% of prescription of Jian Pi Yi Shen Hua Tan Granules and 95% dextrin and conventional treatment of ischemic stroke.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Jian Pi Yi Shen Hua Tan Granules</intervention_name>
    <description>Jianpi Yishen Huatan Granules contain Herba cistanche，Fructus Alpinia Oxyphyllae，Rhodiola rosea, Polygala tenuifolia willd and Coptis chinensis.Jianpi Yishen Huatan Granules dissolved in water of 100 ml ,po, bid of each 90-days cycle. Number of treatment cycles: one</description>
    <arm_group_label>Jian Pi Yi Shen Hua Tan Granules group</arm_group_label>
    <other_name>Jianpi Yishen Huatan Granules group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the placebo group</intervention_name>
    <description>Treat with the placebo which contain 5% of prescription of Jian Pi Yi Shen Hua Tan Granules and 95% dextrin.The placebo dissolved in water of 100 ml ,po, bid of each 90-days cycle. Number of cycles: one</description>
    <arm_group_label>the Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients conform to the diagnostic criteria of acute ischemic stroke Online
             Certificate Status Protocol classification of cerebral infarction : Partial Anterior
             Circulation Infarct, Posterior Circulation Infarct or Lacunar Infarction - Stroke
             onset within 14 days

          -  Neuropsychological assessments: Montreal Cognitive Assessment Scale scores less than
             26 points or scores less than 27 points，MMSE scores range from 19 points to 26 points

          -  Age from forty to eighty, gender not limited

          -  Informed and signed the informed consent

        Exclusion Criteria:

          -  Transient Ischemic Attack

          -  Online Certificate Status Protocol classification of cerebral infarction is a total
             anterior circulation infarction

          -  Stroke patients with the causes of cerebral hemorrhage, subarachnoid hemorrhage, brain
             tumors, brain injury, or blood diseases and so on.

          -  Stroke with an onset of more than 14 days

          -  Cerebral embolism caused by atrial fibrillation resulted from rheumatic heart disease,
             coronary heart disease and other heart diseases.

          -  Patients who cannot cooperate with the check due to serious visual, hearing
             dysfunction, apraxia, aphasia.

          -  Patients with other neurological diseases which can affect cognitive function (for
             example: severe Parkinson's disease, normal pressure hydrocephalus, brain tumors,
             encephalitis)

          -  Patients with communication difficulties, or psychiatric disease

          -  Depression (Hamilton Depression Scale scores more than or equal to 17 points)
             Diagnosed with alcohol or drug dependence within the past six months

          -  With other diseases which can cause cognitive dysfunction, Such as thyroid
             dysfunction, severe anemia, syphilis, Human Immunodeficiency Virus and so on

          -  With a previous history of stroke and serious sequelae, and cannot cope with
             neuropsychological examination

          -  With severe primary diseases, and cannot comply with the above scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunling Zhang, PhD,MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yunling Zhang, PhD,MD</last_name>
    <phone>+86 10 67689634</phone>
    <email>yunlingzhang2004@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology,Dongfang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100078</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunling Zhang, PhD,MD</last_name>
      <phone>+86 10 67689634</phone>
      <email>yunlingzhang2004@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shunyi Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>101300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hu Zhang, PhD</last_name>
      <phone>+861013716088866</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chongqing Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jian Yang, PhD</last_name>
      <phone>+861013452930675</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangmen Wuyi Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Jiangmen</city>
        <state>Guangdong</state>
        <zip>529000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qing Shi, PhD</last_name>
      <phone>+861013923082181</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>the Affiliated Hospital to Changchun University of Chinese Medicine</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130103</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingquan Li, PhD</last_name>
      <phone>+861018844071779</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2015</study_first_submitted>
  <study_first_submitted_qc>December 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>July 27, 2017</last_update_submitted>
  <last_update_submitted_qc>July 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Yunling Zhang</investigator_full_name>
    <investigator_title>President of Dongfang Hospital</investigator_title>
  </responsible_party>
  <keyword>traditional Chinese medicine granules</keyword>
  <keyword>Cognitive Impairment</keyword>
  <keyword>Acute cerebral infraction</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

